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012.06.0Abstract Aim of the work: To study the prognostic inﬂuence of the preoperative left ventricularmass
index (LVMI) on early postoperative outcome in patients undergoing aortic valve replacement (AVR).
Patients and methods: We studied 61 patients (41 males and 20 females) who underwent elective AVR
for isolated or mixed aortic valve lesions. LVMI was calculated by trans-thoracic echocardiography in
all patients.We classiﬁed our patients into two groups: group 1 patients had increased LVMI (>134 g/
m2 in males and >110 g/m2 in females) and group 2 patients who had normal LVMI. Aortic valve
replacement was done in all patients.
Results: We found 48 (age 28.4 ± 12 years) patients with increased LVMI (group 1) and 13 (age
27.2 ± 12 years)withnormalLVMI (group2). Therewas signiﬁcantly increase in the needof prolonged
use of inotropic support (62.5% versus 31%,P value = 0.041), intensive care unit (ICU) stay and post-
operative hospital stay (4.02 ± 2.1 versus 2.3 ± 1.8 days, P value = 0.011 and 8.4 ± 2.4 versus
6.6 ± 2.8 days, 0.025 respectively) in group 1 compared with group 2. The occurrence of post operative
ventricular arrhythmia and atrial ﬁbrillation (AF) was higher in group 1 but still statistically insigniﬁ-
cant. During post operative period two patients died in group 1 and one patient in group 2.
Conclusion: The increase of LVMI values is associatedwith increased in-hospital morbidity in patients
undergoing aortic valve replacement.
ª 2012 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.01006554042.
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031. Introduction
Left ventricular hypertrophy is a well known predictor of mor-
bidity in hypertensive patients [1]. Many clinical studies
pointed out that compensatory left ventricular hypertrophy
brings down the systolic left ventricular wall stress under con-
trol and thereby maintains its ejection performance in parallel
to afterload increase [2–4].
Natsuaki et al. [5] reported the prognostic inﬂuence of the
preoperative left ventricular mass index (LVMI) on theg by Elsevier B.V. All rights reserved.
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The incomplete recovery of the left ventricular function and
lower late survival after AVR is frequently associated with
residual left ventricular hypertrophy [6].
Our study aim is to study the prognostic inﬂuence of the
preoperative LVMI on early postoperative outcome in patients
undergoing AVR.
2. Patients and methods
A total number of 61 patients who underwent elective AVR for
isolated or mixed aortic valve lesions or combined with other
valve lesions in the Cardio-thoracic Surgery Department of
Assiut University Hospital during a two year period were en-
rolled in this study while patients with heart failure, dilated car-
diomyopathy, concomitant coronary artery disease, or had
previous open heart surgery were excluded from our study.
Full history including cardiac symptoms (dyspnea, orthop-
nea, paroxysmal nocturnal dyspnea, chest pain and low car-
diac output symptoms) was taken from all patients. General
(including body weight and height) and systematic (including
cardiac examination) examinations were done to all patients.
2.1. Echocardiography
Trans-thoracic echocardiography was done by a Hewleltt
Packard (HP 4500) machine to all patients and the LVMI
was calculated by means of formula described by Devereux
and Reichek [6]. According to this formula, LVMI was consid-
ered increased if >134 g/m2 in males and >110 g/m2 in fe-
males. We classiﬁed our patients into two groups: group 1
including patients who had increased LVMI and group 2 pa-
tients who had normal LVMI. Left ventricular end diastolic
diameter (LVEDD), LV end systolic diameter (LVESD), inter
ventricular septal dimensions (IVSD) and posterior wall
dimension (PWD) were measured and fraction shortening
(FS) and ejection fraction were calculated.
2.2. Surgical technique
Standard anesthesia and surgical techniques were used. Extra-
corporeal circulation and myocardial preservation methods
were used. Myocardial protection employed was intermittentTable 1 Demographic details of the preoperative and operative stu
Proﬁle Group 1 Group 2
No of patients 48 (78.7%) 13 (21.3%
Male population 34 (83%) 7 (17%)
Female population 14 (70%) 6 (30%)
Age in years 28.4 ± 11.7 27.2 ± 1
Weight (Kg) 57.7 ± 14.3 51.1 ± 1
Height (cm) 164.3 ± 10 160.2 ±
Chest pain 27 (56.3%) 5 (38.5%
CHF 1 (2.1%) 0 (0%)
Hypertension 20 (41.7%) 4 (30.8%
COPD 1 (2.1%) 0 (0%)
NYHA classP III 29 (60.4%) 3 (23.1%
Aortic stenosis (AS) 15 (31.3%) 2 (15.4%
AR 16 (33.3%) 6 (56.2%
Mixed AR & AS 17 (35.4%) 5 (38.5%
Mitral valve disease 11 (22.9%) 7 (53.8%
AR, aortic regurgitation; CHF, congestive heart failure; COPD, chronic ocold crystalloid cardioplegia which delivered every 30 min
and topical hypothermia was offered by ice slush. Fentanyl cit-
rate was used for induction and maintenance of anesthesia.
Moderate hemodilution and systemic hypothermia were main-
tained during cardiopulmonary bypass.
Bi-leaﬂet prosthetic aortic valves (Carbomedics valves)
were used in all patients. Bi-leaﬂet prosthetic mitral valves
(St. Jude valves) were used in 18 patients who required mitral
valve replacement and modiﬁed De-Vega operation was used
in two patients who required tricuspid annuloplasty.
Morbidity was deﬁned as the presence of one or more of the
following during hospitalization: operative re-intervention for
variable causes, cardiac complications (low cardiac output
which need post operative inotropic support for more than
24 h, atrial or ventricular arrhythmias, need for direct current
[DC] shock and need for temporary pacemaker), central ner-
vous system complications, pulmonary insufﬁciency requiring
prolonged ventilation (P48 h), renal failure, serious infection
and prolonged intensive care unit (ICU) and surgical stay.
Mortality was deﬁned as any mortality occurring at any time
during the hospital stay or within 30 days of surgery.
2.3. Statistical analysis
SPSS (ver. 13) was used for data analysis. Data are expressed
as mean ± SD for continuous data and percentage for cate-
gorical data. Comparison between groups was based on the
Pearson’s Chi-square test or Fisher’s exact test as indicated
for categorical variables and unpaired t-test for continuous
variables. P value is considered signiﬁcant when it is <0.05.3. Results
This study included 61 patients (41 males, 67.2% and 20 fe-
males, 32.8%) with isolated or mixed aortic valve disease with
or without other valvular heart disease.
We found 48 (78.7) patients with increased LVMI (group 1)
and 13 (21.3%) with normal LVMI (group 2).Demographic and
clinical criteria of both groups are comparable except patients
with NYHA classP III with signiﬁcantly high in group 1 pa-
tients (Table 1).dy.
Total P-value
) 61
41 (67% of total patients)
20 (33%)
2.4 0.750
5.2 0.153
7.1 0.175
) 32 (52.5%) 0.255
1 (1.6%) 0.600
) 24 (39.3%) 0.476
1 (1.6%) 0.600
) 32 (52.5%) 0.017
) 17 (27.9%) 0.493
) 22 (36.1%)
) 22 (36.1%) >0.05
) 18 (29.5%)
bstructive pulmonary disease; NYHA, New York Heart Association.
Table 2 Echocardiographic data in both groups.
Echocardiographic data Group 1 Group 2 P value
Left ventricular EF% 58.4 ± 10.2 66.2 ± 8.3 0.014
Left ventricular FS% 35.7 ± 8.1 38.5 ± 0.7 0.248
EDD (cm) 6.8 ± 0.8 5.0 ± 0.7 0.000
ESD (cm) 4.6 ± 0.7 3.2 ± 0.6 0.000
IVSD (cm) 1.0 ± 1.9 0.8 ± 0.2 0.001
PWD (cm) 1.0 ± 0.2 0.8 ± 0.2 0.001
EF, ejection fraction; FS, fraction shortening; EDD, end diastolic
diameter; ESD, end systolic diameter; IVSD, inter ventricular septal
dimension; PWD, posterior wall dimensions.
Implications of left ventricular mass index on early postoperative outcome in patients 1333.1. Echocardiographic data
The ejection fraction was relatively still preserved in both
groups (58.4 ± 10.2% in group 1 and 66.2 ± 8.3%) however,
it was statistically signiﬁcantly lower (P value 0.014) in group
1. There was a highly signiﬁcant increase in LV dimensions in
group 1 than group 2 (Table 2).
3.2. Operative data
The aortic cross clamp time (ischemic time) was 110.4 ± 40
min in group 1 and 114.1 ± 45 min in group 2 (P value =
0.783). The bypass time was 144.0 ± 47 in group 1 and
151.2 ± 54 min in group 2 (P value = 0.638) while the opera-
tion time was 268 ± 87 and 310 ± 96 min in group 1 and
group 2 respectively.
3.3. Post operative outcomes
3.3.1. Cardiac outcomes
There was signiﬁcant increase in the need of prolonged use of
inotropic support (more than 24 h) in post operative period in
group 1 patients than group 2 patients (62.5%, 31% respec-
tively, P value 0.041) (Table 3). There is no statistically signif-
icant difference in the bypass or ischemic time between both
groups.
The total number of patients with post-operative atrial ﬁbril-
lation (AF) is 21 patients (18 with high LVMI and 3with normal
LVMI) and 13 patients developed post operative ventricular
arrhythmias (12 had high LVMI and one patient had normal
LVMI). In spite of the higher incidence of post operative ventric-
ular arrhythmias (25% ingroup 1versus 7.7% ingroup 2) (Table
3) and post-operative AF (37.5% in group 1 versus 23.1% in
group 2) (Table 3) still therewas no statistical difference between
the two groups.Table 3 Comparison between group 1 and group 2 in post operati
Parameter Group 1
Inotropic support 30 (62.5%)
ICU stay in days 4.02 ± 2.1
In-hospital stay in days 8.4 ± 2.4
Ventricular arrhythmias 12 (25%)
Atrial ﬁbrillation 18 (37.5%)
Respiratory failure 1 (2.1%)
Bleeding 1 (2.1%)
Mediastinitis 1 (2.1%)
In-hospital mortality 2 (4.2%)The surgeons have applied temporary pacemaker in 4 pa-
tients in group 1 and group 2 (P value 0.94).
We had only two patients presented with post-operative left
sided heart failure in group 1 while there were no patients in
group 2 (P value 0.63).
Regarding the ICU stay, there was a statistically signiﬁcant
increase in the period of ICU stay in group 1 compared with
group 2 (4.02 ± 2.1 versus 2.3 ± 1.8 days respectively, P value
0.011) and this was reﬂected on post-operative hospital stay
(8.4 ± 2.4 versus 6.6 ± 2.8 days respectively,P value = 0.025).3.3.2. Non cardiac outcomes: (Table 3)
3.3.2.1. Regarding respiratory failure. Only one patient has pre-
sented by respiratory failure in the post operative period who
was in group 1. Two patients had mediastinitis as post opera-
tive complication one in group 1 and the other in group 2. Two
patients died in group 1 due to low cardiac output syndrome.
One patient died in group 2 due to stuck mitral valve.
4. Discussion
Many factors that increase operative morbidity and mortality
in patients undergoing AVR have been identiﬁed, these factors
include: LV dysfunction, associated coronary artery disease,
renal insufﬁciency, advanced age, prior AVR, aortic regurgita-
tion, AF, patients’ prosthesis mismatch, type of prosthesis and
cardio- pulmonary bypass time [7–9]. LV dysfunction contin-
ues to associate with a high mortality risk despite surgical
and cardiological improvements [10–12].
Elevated LVMI has also been considered as a risk factor for
increased morbidity and mortality in several circumstances by
investigators reported in the literature [13,3].
In our study we focused on the LVMI as a preoperative
predictor for the morbidity and mortality that occurs after
AVR, as other factors that participate in the poor outcome
for example associated coronary artery, renal insufﬁciency, li-
ver disease, advanced age, and prior AVR were excluded.
We found that in patients with increased level of LVMI
there was increased incidence of in hospital unfavorable clini-
cal events, length of in hospital stay either in the ICU or post
operative in hospital stay. These results are similar to those of
Mehta et al., [3] and Fuster et al., [4].
In Mehta et al., [3], they studied 473 consecutive patients
undergoing electiveAVR.The operative complications (respira-
tory failure, renal insufﬁciency, congestive heart failure and at-
rial and ventricular arrhythmias) were signiﬁcantly increased
in patients with increasedLVMI. The need for inotropic support
more than 24 hrs, the ICU stay and the post operative hospitalve outcomes.
Group 2 Total P value
4 (31%) 34 (56%) 0.041
2.3 ± 1.8 3.66 ± 2.19 0.011
6.6 ± 2.8 8.00 ± 2.54 0.025
1 (8%) 13 (21%) 0.264
3 (23%) 21 (34%) 0.512
0 (0%) 1 (1.6%) 1.000
0 (0%) 1 (1.6%) 1.000
1 (7.7%) 2 (3.3%) 0.384
1 (7.6%) 3 (4.9%) 0.519
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which agreed with our results. We differ from Mehta et al., [3]
because we did not ﬁnd post operative renal or hepatic failure
in our patients and respiratory failure only in one patient.
Several mechanisms may operate in elevating the risk
accompanying an increase in the LVMI in AVR patients.
Excessive LV hypertrophy has been shown to be associated
with contractile impairment and pump dysfunction, leading
to congestive heart failure. Furthermore, it leads to diastolic
dysfunction with abnormal relaxation. Other studies have
reported abnormalities of coronary reserve in patients with
increased LVMI in the absence of epicardial coronary ar-
tery disease [14,15]. This hypertrophied LV posseses a con-
siderable limitation for effective cardio-protection during
ischemic arrest. LV hypertrophy predisposes to the develop-
ment of cardiac arrhythmias and sudden cardiac death
[16,17].
In our study we observed that there was an increase in the
occurrence of LV arrhythmias and AF in patients with in-
creased LVMI than normal LVMI but still statistically insig-
niﬁcant. This matches with results of Fuster et al., [3] and
Fuster [18] who found that there was statistically insigniﬁcant
difference of post operative AF between patients with in-
creased LVMI and normal LVMI. On other hand our ﬁndings
differ from Mehta et al., [3] who, found that there was signif-
icant increase in the occurrence of post operative AF and ven-
tricular arrhythmias in patients with increased LVMI.
In our patients the mortality accounts for 4.2% in patients
with increased LVMI and these ﬁndings are considered as a
low mortality (may be explained by low risk characters of our
patients) if compared with other studies like Mehta et al., [3]
where the mortality was 17% in patients with increased LVMI
and Fuster et al., [4] where the mortality was 11% in patients
with increased LVMI.5. Limitations
The relatively the fewer number of patients and the low risk
characters of our patients (relatively young, no liver, kidney
or coronary artery disease, elective and no redo patients) may
play a role in lower morbidity and mortality of our patients.6. Conclusion
The increase of LVMI values is associated with increased in-
hospital morbidity in patients undergoing aortic valve replace-
ment. This ﬁnding calls for special attention to perioperative
management of such patients.
There is no difference of mortality between two groups,
mostly due to the low overall mortality in our study. So in spite
of the increase of LVMI as an important preoperative risk fac-
tor, other risk factors like associated liver and renal disease or
coronary artery disease which may participate with LVMI le-
vel in the poor outcome should be considered.7. Recommendations
We need to study more number of patients and in higher risk
characters with a longer follow up period.References
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